RATIOS
Krebs Biochemicals & Industries Ltd.
BSE
Jun 02, 02:32
74.55
-0.77 ( -1.02%)
Volume
239
Prev. Close
75.32
Open Price
75.00
Bid Price(Qty.)
74.55 (91)
Offer Pr.(Qty.)
74.99 (10)
NSE
Jun 02, 02:23
74.40
-0.97 ( -1.29%)
Volume
796
Prev. Close
75.37
Open Price
74.05
Bid Price(Qty.)
74.45 (3)
Offer Pr.(Qty.)
74.99 (1)
You can view the
Ratio Analysis
for the last 5 years.
|
ISIN No
|
INE268B01013
|
Market Cap. ( ₹ in Cr. )
|
160.41
|
P/BV
|
-1.10
|
Book Value ( ₹ )
|
-67.83
|
|
BSE Code
|
524518
|
52 Week High/Low ( ₹ )
|
129/61
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
NSE Code
|
KREBSBIOEQ
|
Book Closure
|
27/09/2023
|
EPS ( ₹ )
|
0.00
|
Div Yield (%)
|
0.00
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -12.49 | -9.16 | -11.30 | -20.81 | -14.53 |
| Diluted EPS (Rs.) | -12.49 | -9.16 | -11.30 | -20.81 | -14.53 |
| Cash EPS (Rs.) | -9.39 | -6.01 | -8.41 | -17.73 | -11.84 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -67.83 | -55.29 | -46.13 | -34.83 | -21.78 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -67.83 | -55.29 | -46.13 | -34.83 | -21.78 |
| Revenue From Operations / Share (Rs.) | 20.09 | 23.39 | 24.18 | 27.69 | 27.37 |
| PBDIT / Share (Rs.) | -6.64 | -3.84 | -7.03 | -15.23 | -8.64 |
| PBIT / Share (Rs.) | -9.74 | -6.97 | -10.07 | -18.15 | -11.25 |
| PBT / Share (Rs.) | -12.49 | -9.15 | -11.45 | -20.65 | -14.45 |
| Net Profit / Share (Rs.) | -12.49 | -9.15 | -11.45 | -20.65 | -14.45 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | -33.06 | -16.40 | -29.07 | -55.00 | -31.57 |
| PBIT Margin (%) | -48.50 | -29.82 | -41.65 | -65.55 | -41.11 |
| PBT Margin (%) | -62.16 | -39.12 | -47.36 | -74.58 | -52.80 |
| Net Profit Margin (%) | -62.19 | -39.12 | -47.36 | -74.58 | -52.80 |
| Return on Capital Employeed (%) | -32.07 | -12.92 | -17.25 | -35.02 | -19.88 |
| Return On Assets (%) | -15.93 | -11.07 | -14.11 | -23.45 | -17.81 |
| Long Term Debt / Equity (X) | -1.10 | -0.44 | -0.43 | -0.03 | -2.35 |
| Total Debt / Equity (X) | -1.45 | -0.53 | -0.53 | -0.17 | -2.35 |
| Asset Turnover Ratio (%) | 0.24 | 0.28 | 0.28 | 0.34 | 0.36 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 0.09 | 0.28 | 0.32 | 0.45 | 0.44 |
| Quick Ratio (X) | 0.04 | 0.12 | 0.08 | 0.12 | 0.09 |
| Inventory Turnover Ratio (X) | 0.31 | 0.49 | 0.81 | 2.19 | 1.62 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | -2.42 | -1.76 | -5.10 | -6.09 | -2.70 |
| Interest Coverage Ratio (Post Tax) (%) | -3.56 | -3.21 | -7.30 | -7.26 | -3.52 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 356.07 | 324.85 | 304.75 | 451.99 | 274.16 |
| EV / Net Operating Revenue (X) | 8.22 | 6.44 | 5.85 | 7.57 | 5.11 |
| EV / EBITDA (X) | -24.86 | -39.27 | -20.10 | -13.76 | -16.17 |
| MarketCap / Net Operating Revenue (X) | 3.32 | 2.61 | 2.33 | 5.18 | 3.25 |
| Price / BV (X) | -0.98 | -1.10 | -1.22 | -4.12 | -4.08 |
| Price / Net Operating Revenue (X) | 3.32 | 2.61 | 2.33 | 5.18 | 3.25 |
| EarningsYield | -0.18 | -0.14 | -0.20 | -0.14 | -0.16 |